nodes	percent_of_prediction	percent_of_DWPC	metapath
Fospropofol—Hypoxemia—Gemcitabine—urinary bladder cancer	0.0788	0.0824	CcSEcCtD
Fospropofol—Hepatic insufficiency—Methotrexate—urinary bladder cancer	0.0523	0.0546	CcSEcCtD
Fospropofol—Stinging—Mitomycin—urinary bladder cancer	0.0461	0.0482	CcSEcCtD
Fospropofol—Hypoxemia—Methotrexate—urinary bladder cancer	0.0403	0.0421	CcSEcCtD
Fospropofol—Hypoxia—Thiotepa—urinary bladder cancer	0.0296	0.0309	CcSEcCtD
Fospropofol—Hypoxia—Gemcitabine—urinary bladder cancer	0.0249	0.026	CcSEcCtD
Fospropofol—Tingling sensation—Fluorouracil—urinary bladder cancer	0.0193	0.0202	CcSEcCtD
Fospropofol—Stinging—Fluorouracil—urinary bladder cancer	0.0192	0.0201	CcSEcCtD
Fospropofol—Tingling sensation—Etoposide—urinary bladder cancer	0.0168	0.0176	CcSEcCtD
Fospropofol—Apnoea—Etoposide—urinary bladder cancer	0.0159	0.0166	CcSEcCtD
Fospropofol—Pain—Carboplatin—urinary bladder cancer	0.0153	0.016	CcSEcCtD
Fospropofol—Hepatic failure—Thiotepa—urinary bladder cancer	0.0152	0.0159	CcSEcCtD
Fospropofol—Cough—Mitomycin—urinary bladder cancer	0.0143	0.0149	CcSEcCtD
Fospropofol—Pruritus—Valrubicin—urinary bladder cancer	0.0137	0.0143	CcSEcCtD
Fospropofol—Hepatic failure—Gemcitabine—urinary bladder cancer	0.0128	0.0133	CcSEcCtD
Fospropofol—Hypoxia—Methotrexate—urinary bladder cancer	0.0127	0.0133	CcSEcCtD
Fospropofol—Vomiting—Valrubicin—urinary bladder cancer	0.0123	0.0129	CcSEcCtD
Fospropofol—Headache—Valrubicin—urinary bladder cancer	0.0121	0.0127	CcSEcCtD
Fospropofol—Nausea—Valrubicin—urinary bladder cancer	0.0115	0.012	CcSEcCtD
Fospropofol—Pain—Mitomycin—urinary bladder cancer	0.0114	0.0119	CcSEcCtD
Fospropofol—Apnoea—Methotrexate—urinary bladder cancer	0.00954	0.00997	CcSEcCtD
Fospropofol—Stinging—Epirubicin—urinary bladder cancer	0.00934	0.00976	CcSEcCtD
Fospropofol—Stinging—Doxorubicin—urinary bladder cancer	0.00864	0.00904	CcSEcCtD
Fospropofol—Angiopathy—Thiotepa—urinary bladder cancer	0.00856	0.00895	CcSEcCtD
Fospropofol—Mediastinal disorder—Thiotepa—urinary bladder cancer	0.0085	0.00889	CcSEcCtD
Fospropofol—Vomiting—Mitomycin—urinary bladder cancer	0.00848	0.00886	CcSEcCtD
Fospropofol—Headache—Mitomycin—urinary bladder cancer	0.00835	0.00873	CcSEcCtD
Fospropofol—Nausea—Mitomycin—urinary bladder cancer	0.00792	0.00828	CcSEcCtD
Fospropofol—Ventricular tachycardia—Epirubicin—urinary bladder cancer	0.00757	0.00791	CcSEcCtD
Fospropofol—Angiopathy—Gemcitabine—urinary bladder cancer	0.0072	0.00753	CcSEcCtD
Fospropofol—Cough—Thiotepa—urinary bladder cancer	0.00717	0.00749	CcSEcCtD
Fospropofol—Mediastinal disorder—Gemcitabine—urinary bladder cancer	0.00715	0.00748	CcSEcCtD
Fospropofol—Ventricular tachycardia—Doxorubicin—urinary bladder cancer	0.007	0.00732	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Thiotepa—urinary bladder cancer	0.00695	0.00726	CcSEcCtD
Fospropofol—Mediastinal disorder—Cisplatin—urinary bladder cancer	0.00667	0.00697	CcSEcCtD
Fospropofol—Nervous system disorder—Thiotepa—urinary bladder cancer	0.00657	0.00687	CcSEcCtD
Fospropofol—ALPL—NOTCH1 regulation of human endothelial cell calcification—JAG1—urinary bladder cancer	0.00655	0.15	CbGpPWpGaD
Fospropofol—Hepatic failure—Methotrexate—urinary bladder cancer	0.00653	0.00683	CcSEcCtD
Fospropofol—Skin disorder—Thiotepa—urinary bladder cancer	0.00651	0.00681	CcSEcCtD
Fospropofol—Angiopathy—Etoposide—urinary bladder cancer	0.00615	0.00643	CcSEcCtD
Fospropofol—Hepatic failure—Epirubicin—urinary bladder cancer	0.00611	0.00639	CcSEcCtD
Fospropofol—Mediastinal disorder—Etoposide—urinary bladder cancer	0.00611	0.00639	CcSEcCtD
Fospropofol—Cough—Gemcitabine—urinary bladder cancer	0.00603	0.0063	CcSEcCtD
Fospropofol—Paraesthesia—Thiotepa—urinary bladder cancer	0.00602	0.00629	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Gemcitabine—urinary bladder cancer	0.00584	0.00611	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Thiotepa—urinary bladder cancer	0.00579	0.00605	CcSEcCtD
Fospropofol—Pain—Thiotepa—urinary bladder cancer	0.00573	0.00599	CcSEcCtD
Fospropofol—Hepatic failure—Doxorubicin—urinary bladder cancer	0.00565	0.00591	CcSEcCtD
Fospropofol—Nervous system disorder—Gemcitabine—urinary bladder cancer	0.00553	0.00578	CcSEcCtD
Fospropofol—Skin disorder—Gemcitabine—urinary bladder cancer	0.00548	0.00573	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—urinary bladder cancer	0.00545	0.00569	CcSEcCtD
Fospropofol—Nervous system disorder—Fluorouracil—urinary bladder cancer	0.00544	0.00569	CcSEcCtD
Fospropofol—Hypotension—Gemcitabine—urinary bladder cancer	0.00527	0.00551	CcSEcCtD
Fospropofol—Hypotension—Fluorouracil—urinary bladder cancer	0.00518	0.00542	CcSEcCtD
Fospropofol—Nervous system disorder—Cisplatin—urinary bladder cancer	0.00515	0.00539	CcSEcCtD
Fospropofol—Cough—Etoposide—urinary bladder cancer	0.00515	0.00538	CcSEcCtD
Fospropofol—Skin disorder—Cisplatin—urinary bladder cancer	0.00511	0.00534	CcSEcCtD
Fospropofol—Paraesthesia—Gemcitabine—urinary bladder cancer	0.00506	0.00529	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Etoposide—urinary bladder cancer	0.00499	0.00522	CcSEcCtD
Fospropofol—Paraesthesia—Fluorouracil—urinary bladder cancer	0.00498	0.00521	CcSEcCtD
Fospropofol—Hypotension—Cisplatin—urinary bladder cancer	0.00491	0.00514	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Gemcitabine—urinary bladder cancer	0.00487	0.00509	CcSEcCtD
Fospropofol—Pain—Gemcitabine—urinary bladder cancer	0.00482	0.00504	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Fluorouracil—urinary bladder cancer	0.00479	0.00501	CcSEcCtD
Fospropofol—Pruritus—Thiotepa—urinary bladder cancer	0.00474	0.00496	CcSEcCtD
Fospropofol—Pain—Fluorouracil—urinary bladder cancer	0.00474	0.00496	CcSEcCtD
Fospropofol—Paraesthesia—Cisplatin—urinary bladder cancer	0.00472	0.00494	CcSEcCtD
Fospropofol—Skin disorder—Etoposide—urinary bladder cancer	0.00468	0.00489	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.00454	0.00474	CcSEcCtD
Fospropofol—Hypotension—Etoposide—urinary bladder cancer	0.0045	0.0047	CcSEcCtD
Fospropofol—Pain—Cisplatin—urinary bladder cancer	0.00449	0.0047	CcSEcCtD
Fospropofol—ALPL—Endochondral Ossification—HDAC4—urinary bladder cancer	0.00441	0.101	CbGpPWpGaD
Fospropofol—Paraesthesia—Etoposide—urinary bladder cancer	0.00432	0.00452	CcSEcCtD
Fospropofol—Vomiting—Thiotepa—urinary bladder cancer	0.00426	0.00446	CcSEcCtD
Fospropofol—Headache—Thiotepa—urinary bladder cancer	0.0042	0.00439	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.00416	0.00435	CcSEcCtD
Fospropofol—Pain—Etoposide—urinary bladder cancer	0.00412	0.00431	CcSEcCtD
Fospropofol—Pruritus—Gemcitabine—urinary bladder cancer	0.00399	0.00417	CcSEcCtD
Fospropofol—Nausea—Thiotepa—urinary bladder cancer	0.00398	0.00416	CcSEcCtD
Fospropofol—Pruritus—Fluorouracil—urinary bladder cancer	0.00392	0.0041	CcSEcCtD
Fospropofol—ALPL—NOTCH1 regulation of human endothelial cell calcification—FGFR3—urinary bladder cancer	0.00386	0.0884	CbGpPWpGaD
Fospropofol—Angiopathy—Methotrexate—urinary bladder cancer	0.00368	0.00385	CcSEcCtD
Fospropofol—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.00366	0.00383	CcSEcCtD
Fospropofol—Vomiting—Gemcitabine—urinary bladder cancer	0.00359	0.00375	CcSEcCtD
Fospropofol—Headache—Gemcitabine—urinary bladder cancer	0.00353	0.00369	CcSEcCtD
Fospropofol—Vomiting—Fluorouracil—urinary bladder cancer	0.00353	0.00369	CcSEcCtD
Fospropofol—Headache—Fluorouracil—urinary bladder cancer	0.00347	0.00363	CcSEcCtD
Fospropofol—Angiopathy—Epirubicin—urinary bladder cancer	0.00345	0.0036	CcSEcCtD
Fospropofol—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.00342	0.00358	CcSEcCtD
Fospropofol—Pruritus—Etoposide—urinary bladder cancer	0.00341	0.00356	CcSEcCtD
Fospropofol—Nausea—Gemcitabine—urinary bladder cancer	0.00335	0.0035	CcSEcCtD
Fospropofol—Vomiting—Cisplatin—urinary bladder cancer	0.00334	0.00349	CcSEcCtD
Fospropofol—Nausea—Fluorouracil—urinary bladder cancer	0.00329	0.00344	CcSEcCtD
Fospropofol—Angiopathy—Doxorubicin—urinary bladder cancer	0.00319	0.00334	CcSEcCtD
Fospropofol—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.00317	0.00331	CcSEcCtD
Fospropofol—Nausea—Cisplatin—urinary bladder cancer	0.00312	0.00326	CcSEcCtD
Fospropofol—Cough—Methotrexate—urinary bladder cancer	0.00308	0.00322	CcSEcCtD
Fospropofol—Vomiting—Etoposide—urinary bladder cancer	0.00306	0.0032	CcSEcCtD
Fospropofol—Headache—Etoposide—urinary bladder cancer	0.00302	0.00315	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.00299	0.00312	CcSEcCtD
Fospropofol—Cough—Epirubicin—urinary bladder cancer	0.00289	0.00302	CcSEcCtD
Fospropofol—Nausea—Etoposide—urinary bladder cancer	0.00286	0.00299	CcSEcCtD
Fospropofol—Nervous system disorder—Methotrexate—urinary bladder cancer	0.00283	0.00296	CcSEcCtD
Fospropofol—Skin disorder—Methotrexate—urinary bladder cancer	0.0028	0.00293	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.0028	0.00292	CcSEcCtD
Fospropofol—Hypotension—Methotrexate—urinary bladder cancer	0.0027	0.00282	CcSEcCtD
Fospropofol—Cough—Doxorubicin—urinary bladder cancer	0.00267	0.00279	CcSEcCtD
Fospropofol—Nervous system disorder—Epirubicin—urinary bladder cancer	0.00265	0.00277	CcSEcCtD
Fospropofol—Skin disorder—Epirubicin—urinary bladder cancer	0.00262	0.00274	CcSEcCtD
Fospropofol—Paraesthesia—Methotrexate—urinary bladder cancer	0.00259	0.00271	CcSEcCtD
Fospropofol—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.00259	0.00271	CcSEcCtD
Fospropofol—Hypotension—Epirubicin—urinary bladder cancer	0.00252	0.00264	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00249	0.0026	CcSEcCtD
Fospropofol—Pain—Methotrexate—urinary bladder cancer	0.00247	0.00258	CcSEcCtD
Fospropofol—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.00245	0.00256	CcSEcCtD
Fospropofol—Skin disorder—Doxorubicin—urinary bladder cancer	0.00243	0.00254	CcSEcCtD
Fospropofol—Paraesthesia—Epirubicin—urinary bladder cancer	0.00242	0.00253	CcSEcCtD
Fospropofol—Hypotension—Doxorubicin—urinary bladder cancer	0.00233	0.00244	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.00233	0.00244	CcSEcCtD
Fospropofol—Pain—Epirubicin—urinary bladder cancer	0.00231	0.00241	CcSEcCtD
Fospropofol—Paraesthesia—Doxorubicin—urinary bladder cancer	0.00224	0.00235	CcSEcCtD
Fospropofol—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.00216	0.00225	CcSEcCtD
Fospropofol—Pain—Doxorubicin—urinary bladder cancer	0.00214	0.00223	CcSEcCtD
Fospropofol—Pruritus—Methotrexate—urinary bladder cancer	0.00204	0.00213	CcSEcCtD
Fospropofol—Pruritus—Epirubicin—urinary bladder cancer	0.00191	0.002	CcSEcCtD
Fospropofol—Vomiting—Methotrexate—urinary bladder cancer	0.00183	0.00192	CcSEcCtD
Fospropofol—Headache—Methotrexate—urinary bladder cancer	0.00181	0.00189	CcSEcCtD
Fospropofol—Pruritus—Doxorubicin—urinary bladder cancer	0.00177	0.00185	CcSEcCtD
Fospropofol—Vomiting—Epirubicin—urinary bladder cancer	0.00172	0.00179	CcSEcCtD
Fospropofol—Nausea—Methotrexate—urinary bladder cancer	0.00171	0.00179	CcSEcCtD
Fospropofol—Headache—Epirubicin—urinary bladder cancer	0.00169	0.00177	CcSEcCtD
Fospropofol—Nausea—Epirubicin—urinary bladder cancer	0.0016	0.00168	CcSEcCtD
Fospropofol—Vomiting—Doxorubicin—urinary bladder cancer	0.00159	0.00166	CcSEcCtD
Fospropofol—Headache—Doxorubicin—urinary bladder cancer	0.00156	0.00164	CcSEcCtD
Fospropofol—Nausea—Doxorubicin—urinary bladder cancer	0.00148	0.00155	CcSEcCtD
Fospropofol—ALPL—Endochondral Ossification—PLAU—urinary bladder cancer	0.00138	0.0316	CbGpPWpGaD
Fospropofol—ALPL—Endochondral Ossification—FGFR3—urinary bladder cancer	0.00134	0.0306	CbGpPWpGaD
Fospropofol—ALPL—Endochondral Ossification—IGF1—urinary bladder cancer	0.00112	0.0257	CbGpPWpGaD
Fospropofol—ALPL—AGE/RAGE pathway—RHOA—urinary bladder cancer	0.001	0.023	CbGpPWpGaD
Fospropofol—ALPL—Endochondral Ossification—MMP9—urinary bladder cancer	0.000817	0.0187	CbGpPWpGaD
Fospropofol—ALPL—AGE/RAGE pathway—MMP9—urinary bladder cancer	0.000797	0.0183	CbGpPWpGaD
Fospropofol—ALPL—AGE/RAGE pathway—SRC—urinary bladder cancer	0.000735	0.0168	CbGpPWpGaD
Fospropofol—ALPL—AGE/RAGE pathway—EGFR—urinary bladder cancer	0.000644	0.0148	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—SLC19A1—urinary bladder cancer	0.000462	0.0106	CbGpPWpGaD
Fospropofol—GABRG3—Ion channel transport—TRPV1—urinary bladder cancer	0.000443	0.0102	CbGpPWpGaD
Fospropofol—GABRB1—Ion channel transport—TRPV1—urinary bladder cancer	0.000437	0.01	CbGpPWpGaD
Fospropofol—GABRA6—Ion channel transport—TRPV1—urinary bladder cancer	0.000413	0.00948	CbGpPWpGaD
Fospropofol—GABRA4—Ion channel transport—TRPV1—urinary bladder cancer	0.000408	0.00936	CbGpPWpGaD
Fospropofol—ALPL—BDNF signaling pathway—SRC—urinary bladder cancer	0.000394	0.00903	CbGpPWpGaD
Fospropofol—GABRB2—Ion channel transport—TRPV1—urinary bladder cancer	0.000373	0.00856	CbGpPWpGaD
Fospropofol—GABRA5—Ion channel transport—TRPV1—urinary bladder cancer	0.000363	0.00831	CbGpPWpGaD
Fospropofol—GABRA3—Ion channel transport—TRPV1—urinary bladder cancer	0.000356	0.00816	CbGpPWpGaD
Fospropofol—GABRA2—Ion channel transport—TRPV1—urinary bladder cancer	0.00035	0.00802	CbGpPWpGaD
Fospropofol—GABRB3—Ion channel transport—TRPV1—urinary bladder cancer	0.000348	0.00797	CbGpPWpGaD
Fospropofol—GABRG2—Ion channel transport—TRPV1—urinary bladder cancer	0.000341	0.00783	CbGpPWpGaD
Fospropofol—ALB—FOXA2 and FOXA3 transcription factor networks—TFRC—urinary bladder cancer	0.000327	0.00751	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—MPO—urinary bladder cancer	0.000316	0.00725	CbGpPWpGaD
Fospropofol—GABRA1—Ion channel transport—TRPV1—urinary bladder cancer	0.000298	0.00684	CbGpPWpGaD
Fospropofol—ALPL—BDNF signaling pathway—HRAS—urinary bladder cancer	0.000277	0.00635	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000262	0.006	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000258	0.00591	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—MPO—urinary bladder cancer	0.000257	0.0059	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000244	0.0056	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000241	0.00553	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00022	0.00505	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000214	0.00491	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.00021	0.00482	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000207	0.00474	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000205	0.00471	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—MPO—urinary bladder cancer	0.000204	0.00468	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000202	0.00462	CbGpPWpGaD
Fospropofol—GABRG3—Orphan transporters—CREBBP—urinary bladder cancer	0.0002	0.00458	CbGpPWpGaD
Fospropofol—ALB—SLC-mediated transmembrane transport—SLC14A2—urinary bladder cancer	0.000199	0.00455	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—SOD2—urinary bladder cancer	0.000198	0.00455	CbGpPWpGaD
Fospropofol—GABRB1—Orphan transporters—CREBBP—urinary bladder cancer	0.000197	0.00451	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000189	0.00434	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000186	0.00428	CbGpPWpGaD
Fospropofol—GABRA6—Orphan transporters—CREBBP—urinary bladder cancer	0.000186	0.00427	CbGpPWpGaD
Fospropofol—GABRA4—Orphan transporters—CREBBP—urinary bladder cancer	0.000184	0.00422	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—ESR2—urinary bladder cancer	0.000183	0.00419	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000176	0.00405	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000176	0.00404	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—MTHFR—urinary bladder cancer	0.000175	0.00401	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000174	0.00399	CbGpPWpGaD
Fospropofol—GABRB2—Orphan transporters—CREBBP—urinary bladder cancer	0.000168	0.00386	CbGpPWpGaD
Fospropofol—GABRA5—Orphan transporters—CREBBP—urinary bladder cancer	0.000163	0.00375	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—SOD2—urinary bladder cancer	0.000161	0.0037	CbGpPWpGaD
Fospropofol—GABRA3—Orphan transporters—CREBBP—urinary bladder cancer	0.00016	0.00368	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000159	0.00365	CbGpPWpGaD
Fospropofol—GABRA2—Orphan transporters—CREBBP—urinary bladder cancer	0.000158	0.00362	CbGpPWpGaD
Fospropofol—GABRB3—Orphan transporters—CREBBP—urinary bladder cancer	0.000157	0.00359	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000155	0.00355	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000154	0.00354	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—GPX1—urinary bladder cancer	0.000154	0.00353	CbGpPWpGaD
Fospropofol—GABRG2—Orphan transporters—CREBBP—urinary bladder cancer	0.000154	0.00353	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000152	0.00349	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000152	0.00349	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000149	0.00343	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000148	0.0034	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000146	0.00334	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000144	0.0033	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—MTHFR—urinary bladder cancer	0.000142	0.00326	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000142	0.00326	CbGpPWpGaD
Fospropofol—GABRA1—Orphan transporters—CREBBP—urinary bladder cancer	0.000134	0.00308	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.00013	0.00298	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—SOD2—urinary bladder cancer	0.000128	0.00294	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	0.000127	0.00292	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000126	0.00289	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000124	0.00284	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—GPX1—urinary bladder cancer	0.000122	0.00281	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000122	0.00279	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000121	0.00277	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000119	0.00272	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—MTHFR—urinary bladder cancer	0.000113	0.00259	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000104	0.00239	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	0.000104	0.00238	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000103	0.00235	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000101	0.00231	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—CREBBP—urinary bladder cancer	9.72e-05	0.00223	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	9.72e-05	0.00223	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	9.59e-05	0.0022	CbGpPWpGaD
Fospropofol—ALB—Platelet degranulation—IGF1—urinary bladder cancer	9.38e-05	0.00215	CbGpPWpGaD
Fospropofol—ALB—Response to elevated platelet cytosolic Ca2+—IGF1—urinary bladder cancer	8.93e-05	0.00205	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.78e-05	0.00201	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CYP4B1—urinary bladder cancer	8.74e-05	0.002	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.52e-05	0.00195	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—IL2—urinary bladder cancer	8.41e-05	0.00193	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.37e-05	0.00192	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.23e-05	0.00189	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.17e-05	0.00187	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	8.03e-05	0.00184	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—SRC—urinary bladder cancer	8e-05	0.00183	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—CXCL8—urinary bladder cancer	7.72e-05	0.00177	CbGpPWpGaD
Fospropofol—ALB—Vitamin B12 Metabolism—TNF—urinary bladder cancer	7.52e-05	0.00173	CbGpPWpGaD
Fospropofol—GABRG3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	7.34e-05	0.00168	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	7.29e-05	0.00167	CbGpPWpGaD
Fospropofol—GABRB1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	7.23e-05	0.00166	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—PTGS2—urinary bladder cancer	7.2e-05	0.00165	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	7.02e-05	0.00161	CbGpPWpGaD
Fospropofol—GABRA6—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	6.84e-05	0.00157	CbGpPWpGaD
Fospropofol—GABRA4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	6.76e-05	0.00155	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—EP300—urinary bladder cancer	6.62e-05	0.00152	CbGpPWpGaD
Fospropofol—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	6.18e-05	0.00142	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—TNF—urinary bladder cancer	6.12e-05	0.0014	CbGpPWpGaD
Fospropofol—GABRA5—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	6e-05	0.00138	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	5.95e-05	0.00136	CbGpPWpGaD
Fospropofol—GABRA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	5.9e-05	0.00135	CbGpPWpGaD
Fospropofol—GABRA2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	5.79e-05	0.00133	CbGpPWpGaD
Fospropofol—GABRB3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	5.76e-05	0.00132	CbGpPWpGaD
Fospropofol—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	5.65e-05	0.0013	CbGpPWpGaD
Fospropofol—GABRB3—BDNF signaling pathway—HRAS—urinary bladder cancer	5.63e-05	0.00129	CbGpPWpGaD
Fospropofol—GABRG3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.52e-05	0.00127	CbGpPWpGaD
Fospropofol—GABRB1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.44e-05	0.00125	CbGpPWpGaD
Fospropofol—ALB—Folate Metabolism—TP53—urinary bladder cancer	5.4e-05	0.00124	CbGpPWpGaD
Fospropofol—GABRA1—SIDS Susceptibility Pathways—TNF—urinary bladder cancer	5.37e-05	0.00123	CbGpPWpGaD
Fospropofol—GABRA6—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.15e-05	0.00118	CbGpPWpGaD
Fospropofol—GABRA4—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	5.08e-05	0.00116	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTZ1—urinary bladder cancer	4.98e-05	0.00114	CbGpPWpGaD
Fospropofol—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—HRAS—urinary bladder cancer	4.94e-05	0.00113	CbGpPWpGaD
Fospropofol—GABRG3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.88e-05	0.00112	CbGpPWpGaD
Fospropofol—ALB—Selenium Micronutrient Network—TNF—urinary bladder cancer	4.86e-05	0.00112	CbGpPWpGaD
Fospropofol—GABRB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.81e-05	0.0011	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTO2—urinary bladder cancer	4.72e-05	0.00108	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NAT1—urinary bladder cancer	4.72e-05	0.00108	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—HPGDS—urinary bladder cancer	4.65e-05	0.00107	CbGpPWpGaD
Fospropofol—GABRB2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.65e-05	0.00107	CbGpPWpGaD
Fospropofol—GABRA6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.55e-05	0.00104	CbGpPWpGaD
Fospropofol—GABRA5—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.51e-05	0.00103	CbGpPWpGaD
Fospropofol—GABRA4—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.49e-05	0.00103	CbGpPWpGaD
Fospropofol—GABRA3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.43e-05	0.00102	CbGpPWpGaD
Fospropofol—GABRA2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.36e-05	0.000999	CbGpPWpGaD
Fospropofol—GABRB3—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.33e-05	0.000992	CbGpPWpGaD
Fospropofol—ALB—Metabolism—UGT2B7—urinary bladder cancer	4.32e-05	0.000991	CbGpPWpGaD
Fospropofol—GABRG2—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	4.25e-05	0.000974	CbGpPWpGaD
Fospropofol—GABRG3—Neuronal System—HRAS—urinary bladder cancer	4.23e-05	0.00097	CbGpPWpGaD
Fospropofol—GABRB1—Neuronal System—HRAS—urinary bladder cancer	4.17e-05	0.000955	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—IGF1—urinary bladder cancer	4.16e-05	0.000954	CbGpPWpGaD
Fospropofol—GABRB2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	4.11e-05	0.000942	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.02e-05	0.000921	CbGpPWpGaD
Fospropofol—GABRA5—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.99e-05	0.000915	CbGpPWpGaD
Fospropofol—GABRA6—Neuronal System—HRAS—urinary bladder cancer	3.94e-05	0.000904	CbGpPWpGaD
Fospropofol—GABRA3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.92e-05	0.000898	CbGpPWpGaD
Fospropofol—GABRA4—Neuronal System—HRAS—urinary bladder cancer	3.89e-05	0.000892	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CYP4B1—urinary bladder cancer	3.89e-05	0.000892	CbGpPWpGaD
Fospropofol—GABRA2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.85e-05	0.000883	CbGpPWpGaD
Fospropofol—GABRB3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.82e-05	0.000877	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—RHOA—urinary bladder cancer	3.81e-05	0.000874	CbGpPWpGaD
Fospropofol—GABRG2—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.76e-05	0.000861	CbGpPWpGaD
Fospropofol—GABRA1—Transmission across Chemical Synapses—HRAS—urinary bladder cancer	3.71e-05	0.000852	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IFNA2—urinary bladder cancer	3.71e-05	0.00085	CbGpPWpGaD
Fospropofol—ALB—Metabolism—SLC19A1—urinary bladder cancer	3.67e-05	0.000842	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PRSS3—urinary bladder cancer	3.58e-05	0.000821	CbGpPWpGaD
Fospropofol—GABRB2—Neuronal System—HRAS—urinary bladder cancer	3.56e-05	0.000816	CbGpPWpGaD
Fospropofol—GABRA5—Neuronal System—HRAS—urinary bladder cancer	3.46e-05	0.000793	CbGpPWpGaD
Fospropofol—GABRA3—Neuronal System—HRAS—urinary bladder cancer	3.4e-05	0.000779	CbGpPWpGaD
Fospropofol—GABRA2—Neuronal System—HRAS—urinary bladder cancer	3.34e-05	0.000765	CbGpPWpGaD
Fospropofol—GABRB3—Neuronal System—HRAS—urinary bladder cancer	3.32e-05	0.00076	CbGpPWpGaD
Fospropofol—GABRA1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	3.28e-05	0.000753	CbGpPWpGaD
Fospropofol—GABRG2—Neuronal System—HRAS—urinary bladder cancer	3.26e-05	0.000747	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—IL2—urinary bladder cancer	3.2e-05	0.000733	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—NCOR1—urinary bladder cancer	2.87e-05	0.000658	CbGpPWpGaD
Fospropofol—ALB—Metabolism—TYMP—urinary bladder cancer	2.86e-05	0.000656	CbGpPWpGaD
Fospropofol—GABRA1—Neuronal System—HRAS—urinary bladder cancer	2.85e-05	0.000653	CbGpPWpGaD
Fospropofol—ALB—Platelet activation, signaling and aggregation—SRC—urinary bladder cancer	2.79e-05	0.00064	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—GPX1—urinary bladder cancer	2.75e-05	0.00063	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—PLAU—urinary bladder cancer	2.63e-05	0.000603	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NAT2—urinary bladder cancer	2.59e-05	0.000594	CbGpPWpGaD
Fospropofol—ALB—Metabolism—RRM2—urinary bladder cancer	2.23e-05	0.000512	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—CREBBP—urinary bladder cancer	2.17e-05	0.000498	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IGF1—urinary bladder cancer	2.14e-05	0.000492	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ENO2—urinary bladder cancer	2.07e-05	0.000474	CbGpPWpGaD
Fospropofol—ALB—Metabolism—HPGDS—urinary bladder cancer	2.07e-05	0.000474	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PPARG—urinary bladder cancer	2.06e-05	0.000472	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTT1—urinary bladder cancer	2.01e-05	0.00046	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—CREBBP—urinary bladder cancer	1.98e-05	0.000453	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—RHOA—urinary bladder cancer	1.96e-05	0.00045	CbGpPWpGaD
Fospropofol—ALB—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.88e-05	0.000431	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NQO1—urinary bladder cancer	1.67e-05	0.000382	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—IL2—urinary bladder cancer	1.65e-05	0.000378	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PTGS2—urinary bladder cancer	1.62e-05	0.000371	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—EP300—urinary bladder cancer	1.48e-05	0.000339	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—SRC—urinary bladder cancer	1.44e-05	0.00033	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—PTEN—urinary bladder cancer	1.41e-05	0.000324	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTP1—urinary bladder cancer	1.39e-05	0.000319	CbGpPWpGaD
Fospropofol—ALB—Metabolism of lipids and lipoproteins—EP300—urinary bladder cancer	1.35e-05	0.000309	CbGpPWpGaD
Fospropofol—ALB—Metabolism—TYMS—urinary bladder cancer	1.29e-05	0.000297	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GSTM1—urinary bladder cancer	1.28e-05	0.000293	CbGpPWpGaD
Fospropofol—ALB—Metabolism—NCOR1—urinary bladder cancer	1.28e-05	0.000293	CbGpPWpGaD
Fospropofol—ALB—Metabolism—GPX1—urinary bladder cancer	1.22e-05	0.000281	CbGpPWpGaD
Fospropofol—ALB—Metabolism—ERCC2—urinary bladder cancer	1.2e-05	0.000276	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—KRAS—urinary bladder cancer	1.19e-05	0.000273	CbGpPWpGaD
Fospropofol—ALB—Metabolism—MTHFR—urinary bladder cancer	1.13e-05	0.000259	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—TP53—urinary bladder cancer	1.06e-05	0.000243	CbGpPWpGaD
Fospropofol—ALB—Hemostasis—HRAS—urinary bladder cancer	1.01e-05	0.000232	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PPARG—urinary bladder cancer	9.16e-06	0.00021	CbGpPWpGaD
Fospropofol—ALB—Metabolism—CREBBP—urinary bladder cancer	8.8e-06	0.000202	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PTGS2—urinary bladder cancer	7.21e-06	0.000165	CbGpPWpGaD
Fospropofol—ALB—Metabolism—PTEN—urinary bladder cancer	6.29e-06	0.000144	CbGpPWpGaD
Fospropofol—ALB—Metabolism—EP300—urinary bladder cancer	5.99e-06	0.000137	CbGpPWpGaD
